Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Hoos

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Colorectal Disease|January 13, 2004
Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancerRobert Rosenberg, Jan Friederichs, Ralf Gertler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patientsRobert Rosenberg, Axel Hoos, James Mueller, et al.
Seminars in Oncology|November 16, 2010
Development of ipilimumab: contribution to a new paradigm for cancer immunotherapyAxel Hoos, Ramy Ibrahim, Alan Korman, et al.
Cancer Discovery|September 15, 2023
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data ScienceDarrin D Stuart, Angel Guzman-Perez, Natasja Brooijmans, et al.
The Journal of Surgical Research|February 14, 2002
Xenogeneic DNA immunization in melanoma models for minimal residual diseaseWilliam G Hawkins, Jason S Gold, Nathalie E Blachere, et al.
Surgery|January 20, 2005
Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomasInderpal S Sarkaria, Alexander Stojadinovic, Simon G Talbot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinomaRalf Gertler, Robert Rosenberg, Dominik Stricker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
A clinical development paradigm for cancer vaccines and related biologicsAxel Hoos, Giorgio Parmiani, Kristen Hege, et al.
Blood|August 31, 2016
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapyBruce D Cheson, Stephen Ansell, Larry Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Adrenocortical carcinoma: clinical, morphologic, and molecular characterizationAlexander Stojadinovic, Ronald A Ghossein, Axel Hoos, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Colorectal Disease|January 13, 2004
Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancerRobert Rosenberg, Jan Friederichs, Ralf Gertler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patientsRobert Rosenberg, Axel Hoos, James Mueller, et al.
Seminars in Oncology|November 16, 2010
Development of ipilimumab: contribution to a new paradigm for cancer immunotherapyAxel Hoos, Ramy Ibrahim, Alan Korman, et al.
Cancer Discovery|September 15, 2023
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data ScienceDarrin D Stuart, Angel Guzman-Perez, Natasja Brooijmans, et al.
The Journal of Surgical Research|February 14, 2002
Xenogeneic DNA immunization in melanoma models for minimal residual diseaseWilliam G Hawkins, Jason S Gold, Nathalie E Blachere, et al.
Surgery|January 20, 2005
Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomasInderpal S Sarkaria, Alexander Stojadinovic, Simon G Talbot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinomaRalf Gertler, Robert Rosenberg, Dominik Stricker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
A clinical development paradigm for cancer vaccines and related biologicsAxel Hoos, Giorgio Parmiani, Kristen Hege, et al.
Blood|August 31, 2016
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapyBruce D Cheson, Stephen Ansell, Larry Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Adrenocortical carcinoma: clinical, morphologic, and molecular characterizationAlexander Stojadinovic, Ronald A Ghossein, Axel Hoos, et al.
Pageof 8